Compare WRBY & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WRBY | STAA |
|---|---|---|
| Founded | 2010 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Ophthalmic Goods | Ophthalmic Goods |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 1.2B |
| IPO Year | 2021 | N/A |
| Metric | WRBY | STAA |
|---|---|---|
| Price | $21.84 | $23.12 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 15 | 10 |
| Target Price | ★ $25.43 | $24.56 |
| AVG Volume (30 Days) | ★ 5.9M | 1.5M |
| Earning Date | 11-06-2025 | 02-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.00 | N/A |
| Revenue | ★ $850,580,000.00 | $230,591,000.00 |
| Revenue This Year | $15.47 | N/A |
| Revenue Next Year | $13.06 | $21.97 |
| P/E Ratio | $8,861.17 | ★ N/A |
| Revenue Growth | ★ 14.55 | N/A |
| 52 Week Low | $13.63 | $13.50 |
| 52 Week High | $31.00 | $30.81 |
| Indicator | WRBY | STAA |
|---|---|---|
| Relative Strength Index (RSI) | 42.92 | 41.02 |
| Support Level | $25.71 | $22.90 |
| Resistance Level | $27.29 | $23.74 |
| Average True Range (ATR) | 1.57 | 1.13 |
| MACD | -0.67 | -0.11 |
| Stochastic Oscillator | 3.88 | 6.71 |
Warby Parker Inc is a mission-driven, lifestyle brand that operates at the intersection of design, technology, healthcare, and social enterprise. The company predominantly derives revenue from the sales of eyewear products, optical services, and accessories. The firm sells products and services through its stores, website, and mobile apps. Revenue generated from eyewear products includes the sales of prescription and non-prescription optical glasses and sunglasses, contact lenses, eyewear accessories, and expedited shipping charges.
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.